Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-10-8
pubmed:abstractText
Kidney samples of male Fischer 344 (F-344) rats fed a carcinogenic dose of OTA over 7 days, 21 days and 12 months were analysed for various cell signalling proteins known to be potentially involved in chemical carcinogenicity. OTA was found to increase the phosphorylation of atypical-PKC. This was correlated with a selective downstream activation of the MAP-kinase extracellular regulated kinases isoforms 1 and 2 (ERK1/2) and of their substrates ELK1/2 and p90RSK. Moreover, analysis of effectors acting upstream of PKC indicated a possible mobilisation of the insulin-like growth factor-1 receptor (lGFr) and phosphoinositide-dependent kinase-1 (PDK1) system. An increased histone deacetylase (HDAC) enzymatic activity associated with enhanced HDAC3 protein expression was also observed. These findings are potentially relevant with respect to the understanding of OTA nephrocarcinogenicity. HDAC-induced gene silencing has previously been shown to play a role in tumour development. Furthermore, PKC and the MEK-ERK MAP-kinase pathways are known to play important roles in cell proliferation, cell survival, anti-apoptotic activity and renal cancer development.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3-phosphoinositide-dependent..., http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens, http://linkedlifedata.com/resource/pubmed/chemical/Elk1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylases, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Ochratoxins, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 90-kDa, http://linkedlifedata.com/resource/pubmed/chemical/ets-Domain Protein Elk-1, http://linkedlifedata.com/resource/pubmed/chemical/histone deacetylase 3, http://linkedlifedata.com/resource/pubmed/chemical/ochratoxin A
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0041-008X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
224
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
174-81
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17651772-Animals, pubmed-meshheading:17651772-Blotting, Western, pubmed-meshheading:17651772-Carcinogens, pubmed-meshheading:17651772-Gene Expression Regulation, pubmed-meshheading:17651772-Histone Deacetylases, pubmed-meshheading:17651772-Kidney, pubmed-meshheading:17651772-Kidney Neoplasms, pubmed-meshheading:17651772-MAP Kinase Signaling System, pubmed-meshheading:17651772-Male, pubmed-meshheading:17651772-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:17651772-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:17651772-Ochratoxins, pubmed-meshheading:17651772-Phosphorylation, pubmed-meshheading:17651772-Protein-Serine-Threonine Kinases, pubmed-meshheading:17651772-Rats, pubmed-meshheading:17651772-Rats, Inbred F344, pubmed-meshheading:17651772-Receptor, IGF Type 1, pubmed-meshheading:17651772-Ribosomal Protein S6 Kinases, 90-kDa, pubmed-meshheading:17651772-Time Factors, pubmed-meshheading:17651772-ets-Domain Protein Elk-1
pubmed:year
2007
pubmed:articleTitle
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma.
pubmed:affiliation
Nestlé Research Center, PO Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. maricel.marin-kuan@rdls.nestle.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't